Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.

SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.

Clean medicine developer Genexa roped in Unilever for its $60m series A round while Krafton led storytelling platform developer Pratilipi's $48m series D.

Electric aircraft developer Heart Aerospace raised $35m from investors including Mesa Air and United, while several corporates are set to exit remote access software developer Openpath.

Existing investor Agilent helped the biomedical analysis technology developer close a series C round that pushed its overall funding past $110m.

SBI Group backed Tide in a series C round which doubled the overall funding raised by the digital banking platform developer to $200m.

Corporate partnership CR-CP Life Science Fund led the cancer detection test developer’s series C round, which took its total funding to $120m.

GV participated in a series C round for the online flexible staffing portal at a valuation of $560m, hiking its overall funding to $100m.

Softbank-backed Tridge, a digital trading platform dedicated to the agriculture sector, has secured series C funding to scale up its fulfilment service and expand its global presence.

Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.